Previous Article | Next Article 
Journal of Virology, August 2001, p. 6758-6768, Vol. 75, No. 15
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.6758-6768.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
African Swine Fever Virus Structural Protein pE120R Is
Essential for Virus Transport from Assembly Sites to Plasma
Membrane but Not for Infectivity
Germán
Andrés,*
Ramón
García-Escudero,
Eladio
Viñuela,
María L.
Salas, and
Javier M.
Rodríguez
Centro de Biología Molecular
"Severo Ochoa" (Consejo Superior de Investigaciones
Científicas-Universidad Autónoma de Madrid), Facultad de
Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
Received 16 January 2001/Accepted 2 May 2001
 |
ABSTRACT |
This report examines the role of African swine fever virus (ASFV)
structural protein pE120R in virus replication. Immunoelectron microscopy revealed that protein pE120R localizes at the surface of the
intracellular virions. Consistent with this, coimmunoprecipitation assays showed that protein pE120R binds to the major capsid protein p72. Moreover, it was found that, in cells infected with an ASFV recombinant that inducibly expresses protein p72, the incorporation of
pE120R into the virus particle is dependent on p72 expression. Protein
pE120R was also studied using an ASFV recombinant in which E120R gene
expression is regulated by the Escherichia coli lac repressor-operator system. In the absence of inducer, pE120R expression was reduced about 100-fold compared to that obtained with the parental
virus or the recombinant virus grown under permissive conditions.
One-step virus growth curves showed that, under conditions that repress
pE120R expression, the titer of intracellular progeny was similar to
the total virus yield obtained under permissive conditions, whereas the
extracellular virus yield was about 100-fold lower than in control
infections. Immunofluorescence and electron microscopy demonstrated
that, under restrictive conditions, intracellular mature virions are
properly assembled but remain confined to the replication areas.
Altogether, these results indicate that pE120R is necessary for virus
dissemination but not for virus infectivity. The data also suggest that
protein pE120R might be involved in the microtubule-mediated transport
of ASFV particles from the viral factories to the plasma membrane.
 |
INTRODUCTION |
African swine fever virus
(ASFV), the only member of the new family Asfarviridae, is a
complex enveloped deoxyvirus responsible for a severe disease of
domestic pigs (19, 23, 39, 49). ASFV infects soft ticks of
the Ornithodoros genus and different species of suids, being
the only known arbovirus that contains DNA, ASFV is unique among DNA
viruses in that it resembles the poxviruses in its genome structure and
gene expression strategy but morphologically is similar to the
iridoviruses (39). The viral genome is a double-stranded
DNA molecule of 170 to 190 kbp with terminal inverted repetitions and
terminal cross-links (29, 47). The genome of the ASFV
strain BA71V encodes more than 150 polypeptides, including structural
proteins; a variety of enzymes involved in DNA replication and repair,
gene transcription, and protein modification, and proteins potentially
involved in the modulation of the virus-host interaction (39,
50).
The virus particle possesses a complex structure composed by several
concentric domains with an overall icosahedral shape and an average
diameter of 200 nm (4, 5, 14). The viral core consists of
a DNA-containing nucleoid covered by a thick protein coat, the core
shell. The core is surrounded by an inner lipid envelope and an
icosahedral protein capsid. Extracellular particles possess an
additional envelope derived from the plasma membrane (9).
ASFV particles assemble within cytoplasmic viral factories (4, 9,
10, 31) from precursor membranous structures that probably
represent collapsed cisternae derived from the endoplasmic reticulum
(5, 18, 38). These membranes give rise to the inner viral
envelope, which becomes an icosahedral structure by the progressive
assembly of the capsid layer (5, 27). Envelopment and
capsid formation depend on calcium gradients and ATP (18). The core is formed beneath the inner envelope through the consecutive assembly of the core shell domain and the electron-dense DNA-containing nucleoid (4, 11). The intracellular particles associate
with microtubules to reach the plasma membrane (3, 16) and
are finally released from the cell by budding (9).
The mature virion contains about 50 proteins (25), some of
which are produced by the proteolytic processing of two viral polyproteins by the viral cysteine proteinase pS273R (6).
The core shell proteins p150, p37, p34, and p14, which represent about 25% of the total protein mass of the virus particle, are derived from
polyprotein pp220 (4, 43). Similarly, the structural proteins p35 and p15 are derived from polyprotein pp62
(44). At least three major structural proteins have
DNA-binding properties (8, 30, 32); one of them (protein
5AR) has been located within the nucleoid and is similar to bacterial
histone-like proteins (8). Among the 26 putative membrane
proteins encoded by the ASFV genome (36), the structural
proteins p12 and pE183L have been involved in the virus attachment to
the host cell (1, 13, 28, 34). The icosahedral capsid is
mainly composed by protein p72, which represents about one-third of the
virus protein mass and probably forms the hexagonal capsomers (4,
27).
Despite the emerging information about the ASFV structural components,
little is known on their particular role in virus morphogenesis. To
facilitate this study, our laboratory recently adapted to ASFV an
inducible expression system based on the Escherichia coli
lac operon (27). By using an ASFV recombinant with an
inducible copy of protein p72 gene, the role of the major capsid
protein in virus assembly and also the origin of the inner viral
envelope were analyzed (5, 27). In this report, we have
employed the same strategy to investigate the role of protein pE120R in
ASFV replication. Protein pE120R, also called p14.5, has been
previously characterized as a structural protein expressed as different
molecular weight forms late after infection (30). In vitro
assays revealed that protein pE120R has DNA-binding properties and that
it interacts with a late virus-induced protein of 72 kDa.
Data presented here show that protein pE120R is a capsid component
which associates with the major capsid protein p72. Furthermore, protein pE120R was found to be essential for virus dissemination but
not for infectivity.
 |
MATERIALS AND METHODS |
Cells and viruses.
Vero cells (ATCC CCL81) were grown in
Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal calf
serum (FCS), which was reduced to 2% during viral infection. The ASFV
strain BA71V, adapted to grow in Vero cells, and the recombinant
viruses vGUSREP and vA72 have been already described (24,
27). Highly purified extracellular BA71V was obtained by Percoll
equilibrium centrifugation (12).
Antibodies.
The monospecific rabbit polyclonal serum against
protein pE120R and the mouse monoclonal antibody (MAb) 17L.D3 against
the major capsid protein p72 have been described previously (27, 30, 41). The rabbit polyclonal serum against protein p72 was raised by immunization with protein p72 obtained from polyacrylamide gels after electrophoresis of highly purified ASFV.
Plasmid construction.
(i) pIND1 and pIND2. The transfer
vectors pIND1 and pIND2 for inducible ASFV gene expression were
constructed as follows. A 3.4-kb DNA fragment, containing the
lacZ gene under the control of the strong late ASFV promoter
p72, was purified from
SmaI/SalI-digested plasmid p72GAL10T
(26). After treatment with Klenow enzyme, the
fragment was cloned into the SmaI-digested plasmid p72.I, immediately upstream of a viral inducible promoter (p72.I)
consisting of the strong late promoter p72.4 separated by 6 bp from the core sequence of the E. coli lac operator
O1 (27). The resulting plasmids were called
p72.I.GAL(r) and p72.I.GAL(l). A NotI restriction site was
added to plasmid pUC119 by inserting the self-hybridized oligonucleotide 5'-AATTGCGGCCGC into the unique
EcoRI site. The resulting plasmid was called
pUC119-NotI. Finally, pIND1 and pIND2 plasmids were obtained
by inserting the 3.5-kb KpnI/HindIII fragments from p72.I.GAL(r) and p72.I.GAL(l) into
pUC119-NotI-linearized with KpnI and
HindIII. These vectors are designed to allow the inducible
expression of a target gene after homologous recombination with the
virus vGUSREP, which constitutively expresses the lacI repressor (27). They contain a cassette formed by the
viral inducible promoter p72.I and the lacZ gene
under the control of the strong late promoter p72
(27) that allows the color identification of the
recombinant viruses. This cassette is flanked by a multiple cloning
site formed by XbaI, SalI, PstI, and
HindIII sites, immediately downstream of the inducible
promoter to allow the cloning of the target gene and the necessary
downstream-flanking sequences. A second multiple cloning site formed by
SmaI, KpnI, and NotI sites is located
upstream of the lacZ gene to allow the cloning of the upstream-flanking sequences. The transfer vectors pIND1 and pIND2 differ in the direction of transcription of the lacZ gene
with respect to the inducible promoter.
(ii) pIND1.E120R and pIND2.E120R.
A synthetic DNA fragment
of 1,456 bp, which contains the nucleotide sequence from positions
1417 to +19 relative to the translation initiation codon of the
ASFV E120R gene, was obtained by PCR, using the primers
5'-CCTGCGGCCGCAGCTCGGAAATCGAAGGG and
5'-ACTGGTACCGAGAATTAAAATCTGCCATC, which contain
NotI and KpnI restriction sites (underlined) at their respective 5' ends. Plasmids pIND1.E120R.Fl and pIND2.E120R.Fl were generated by inserting the
KpnI/NotI-digested PCR fragment into
KpnI/NotI-digested pIND1 and pIND2, respectively.
These plasmids contained the upstream flanking sequences of the E120R
gene. The oligonucleotides
5'-GCGCCCGGGGATCCTCTAGAGTCGACATGGCAGATTTTAATTCTCC and
5'-TAACTGCAGGACATTCGCTAAAACTCATCC were used to obtain a
1,341-bp PCR DNA fragment containing the complete E120R open reading
frame sequence (the primers include, respectively, SmaI and
PstI restriction sites at their 5' ends). The PCR fragment
was digested with SmaI and PstI and inserted into
the plasmids pIND1.E120R.Fl and pIND2.E120R.Fl, previously linearized
with XbaI, treated with mung bean nuclease and digested with
PstI, producing the final transfer plasmids pIND1.E120R
and pIND2.E120R, respectively.
Generation of recombinant virus vE120Ri.
Recombinant viruses
were generated essentially as previously described (35)
with minor modifications. Briefly, Vero cells were infected with virus
vGUSREP (27) and transfected with plasmids pIND1.E120R or
pIND2.E120R in the presence of 1 mM IPTG. At 48 h postinfection
(hpi), the cells were harvested and the recombinant viruses were
isolated by sequential rounds of plaque purification in the presence of
1 mM IPTG (isopropyl-
-D-thiogalactopyranoside). Similar
results were obtained with the two plasmids used and, after three
rounds, one virus clone coming from the pIND1.E120R-transfected cells
was selected for further characterization. The structure of this
recombinant virus, named vE120Ri, was confirmed by DNA hybridization analysis.
Plaque assays.
Preconfluent monolayers of Vero cells seeded
in six-well plates were infected with 600 PFU of recombinat vE120Ri or
parental BA71V. After 1 h, the inoculum was removed and the cells
were overlaid with DMEM containing 0.6% Noble agar and 2% FCS in the presence or absence of 1 mM IPTG. Five days later, the medium was
removed and the monolayers were stained with 1% crystal violet.
One-step virus growth curves.
Preconfluent monolayers of
Vero cells were infected with recombinant vE120Ri or parental BA71V at
a multiplicity of infection of 5 PFU per cell. After 1 h, the
inoculum was removed and the cells were washed with fresh DMEM and
overlaid with DMEM supplemented with 2% FCS. IPTG (1 mM) was added
immediately after the adsorption period or at 12, 16, or 20 hpi.
Infected cells with their culture supernatants were harvested at
different times postinfection and centrifuged at 1,000 × g for 5 min. The cell sediment was resuspended in DMEM
supplemented with 2% FCS. Both the cellular fraction and the culture
supernatant were sonicated and separately titrated by plaque assay on
monolayers of Vero cells in the presence of 1 mM IPTG.
Metabolic labeling, immunoprecipitation, and Western
immunoblotting.
Preconfluent monolayers of mock- and
BA71V-infected Vero cells were pulse-labeled from 16 to 18 hpi with 500 µCi of [35S]methionine-[35S]cysteine
(Promix In Vitro Cell Labeling Mix; Amersham Pharmacia Biotech) per ml.
The cells were lysed at 4°C with immunoprecipitation buffer (0.01 M
Tris-HCl, pH 7.5; 0.15 M NaCl; 1% sodium deoxycholate; 1% IGEPAL
CA-630; 0.1% sodium dodecyl sulfate [SDS]) supplemented with
protease inhibitors (Complete EDTA-free Cocktail; Roche). Extracts were
immunoprecipitated with anti-pE120R antibodies immobilized on protein
A-Sepharose (Sigma). Proteins were resolved by SDS-12% polyacrylamide
gel electrophoresis and detected by autoradiography.
For the pulse-chase experiment, preconfluent monolayers of Vero cells,
cultured in 60-mm plates, were infected with ASFV at 20 PFU/cell. At 11 hpi, cells were pulse-labeled for 1 h with 1 mCi of
[35S]methionine-[35S]cysteine in
methionine- and cysteine-free DMEM per ml. Before the pulse, the medium
was replaced with methionine- and cysteine-free DMEM for 15 min to
remove any residual methionine and cysteine. At the end of the labeling
period, the medium was removed and the cells were incubated with fresh
DMEM for different chase periods. The soluble cytoplasm and the
membrane-particulate fractions were obtained as described below. The
extracellular virus fraction was collected from the medium by
centrifugation in a Beckman Airfuge at 133,000 × g for
20 min. Equivalent amounts of the different fractions were
immunoprecitated with anti-pE120R antibodies.
For immunoblotting, samples were electrophoresed in SDS-12%
polyacrylamide gels and transferred to nitrocellulose as described
elsewhere (
4). Protein detection was carried out with
peroxidase-conjugated
antibodies and the ECL System (Amersham Pharmacia
Biotech) according
to the manufacturer's indications. Quantitation of
protein bands
was performed with a Bio-Rad GS710 densitometer and
Quantity One
software (Bio-Rad).
Subcellular fractionation.
Vero cells were mock infected or
were infected with 5 PFU of the BA71V strain per ml or with the
recombinant virus vA72 in the presence or absence of 1.25 mM IPTG. At
24 hpi, cells were resuspended at 107 cells/ml in
homogenization buffer containing 20 mM Tris-HCl (pH 7.5)-0.25 M
sucrose-1 mM EDTA and passed through a 25-gauge syringe 20 times. Cell
breakage was monitored by phase-contrast microscopy. The homogenate was
centrifuged at 500 × g for 5 min to sediment the
nuclei and unbroken cells, and the supernatant was subsequently centrifuged at 100,000 × g for 15 min to separate the
soluble cytoplasm from the membrane-particulate fraction. Analysis of equivalent amounts of both fractions was performed by Western immunoblotting.
Immunofluorescence microscopy.
Preconfluent Vero cells grown
on coverslips were infected with recombinant vE120Ri at 1 PFU per cell
in the presence or absence of 1 mM IPTG. At 18 hpi, infected cells were
fixed with methanol at
20°C for 5 min. After being washed with
phosphate-buffered saline (PBS), cells were blocked for 30 min with 1%
cold fish skin gelatin in PBS. Cells were then incubated for 1 h
with rabbit serum anti-pE120R and mouse MAb (17LD3) anti-p72 diluted
1/200 and 1/20, respectively, in blocking solution. After an extensive washing with PBS, cells were incubated for 1 h with Alexa 488 goat
anti-rabbit immunoglobulin G (IgG) and Alexa 594 goat anti-mouse IgG
(Molecular Probes) diluted 1/1,000 in blocking solution. Finally, coverslips were washed with PBS and mounted with Mowiol/Dabco on glass
slides. Preparations were examined with a Bio-Rad Radiance 2000 confocal laser scanning microscope. Images were processed using Adobe
Photoshop software.
Electron microscopy.
For conventional Epon section analysis,
Vero cells were infected with 10 PFU per cell and fixed at the
indicated times with 2% glutaraldehyde in 200 mM cacodylate buffer (pH
7.4) for 1 h at room temperature. Postfixation was carried out
with 1% OsO4 and 1.5% K3Fe(CN)6
in cacodylate buffer at 4°C for 30 min. After an extensive washing
with distilled water, the samples were dehydrated and embedded in Epon.
For freeze substitution, the infected cells were fixed for 1 h
with 4% formaldehyde and 0.1% glutaraldehyde in 200 mM HEPES
(pH 7.2)
on ice and cryoprotected with 30% glycerol for 30 min.
Specimens were
rapidly frozen in liquid propane (

180°C) and stored
in liquid
nitrogen until use. Freeze substitution was carried
out as described
earlier (
5).
For pre-embedding immunolabeling, ASFV-infected Vero cells were
permeabilized at 24 hpi essentially as described previously
(
45). Permeabilization of the plasma membrane was carried
out
with 20 U of streptolysin O (Sigma) per ml in SLO buffer (0.25
M
sucrose, 50 mM potassium acetate, 5 mM magnesium acetate, 1
mM
dithiothreitol, 25 mM HEPES; pH 7.4). After 15 min at 4°C,
the cells
were incubated in SLO buffer for 15 min at 37°C, extensively
washed
with 0.2 M HEPES (pH 7.2), and lightly fixed with 4% paraformaldehyde
in the same buffer for 10 min at 4°C. Subsequently, the cells
were
washed with ice-cold PBS, blocked with 0.5% cold fish skin
gelatin in
PBS for 1 h, and labeled with a 1/25 dilution of anti-pE120R
antibody in PBS with 1% egg albumin. After being washed for 2
h
with PBS, the cells were incubated with protein A-gold (10 nm)
for
1 h, washed again for 2 h with PBS, fixed with 2%
glutaraldehyde
for 1 h, and processed for conventional Epon
embedding.
Postembedding labeling of ultrathin Lowicryl K4M sections was performed
as described elsewhere (
4). The rabbit polyclonal
antibodies against pE120R and p72 were used at a 1/25 and 1/100
dilutions, respectively, in PBS with 1% egg
albumin.
Specimens were examined at 80 kV in a Jeol 1010 electron microscope and
photographed with a Bioscan 792 charge-coupled device
camera
(1,024 × 1,024 pixels; Gatan). Digital images were processed
with
DigitalMicrograph (Gatan) and Adobe Photoshop software
(Adobe).
 |
RESULTS |
Protein pE120R localizes at the surface of the intracellular
virions.
We first analyzed the localization of protein pE120R in
ASFV-infected cells by immunoelectron microscopy. Ultrathin Lowicryl sections of infected cells processed at 24 hpi by freeze substitution were incubated with a monospecific rabbit anti-pE120R antibody (30) prior to incubation with protein A-gold complexes.
The signal was essentially localized in the virus factories (Fig. 1A),
as well as on virus particles spreading throughout the cytoplasm (not
shown) or budding at the plasma membrane (Fig. 1B). Within the assembly
sites, gold particles were found mainly associated with both immature
and mature icosahedral virus particles (Fig. 1A). In contrast, nonpolyhedral
membranous structures, which are thought to be precursor forms of the
ASFV particles (4), were poorly labeled. No significant
pE120R labeling was associated with the endoplasmic reticulum or other
cellular membranes (not shown). Within the virus particles, most of the
labeling was associated with the periphery of the virions, which was
particularly evident when individual cross-sectioned budding particles
were visualized (Fig. 1B).

View larger version (126K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoelectron microscopy of protein pE120R in
BA71V-infected cells. (A and B) Ultrathin Lowicryl K4M sections of
infected Vero cells fixed at 24 hpi and processed by freeze
substitution were incubated with anti-pE120R antibodies followed by
protein A-gold (10 nm). (A) Within the virus factory, the labeling was
mainly associated with mature particles and icosahedral immature
virions lacking an electrondense nucleoid. In contrast, the precursor
membranous structures surrounding the virus particles were weakly
labeled. (B) A strong and peripheral labeling was also detected on ASFV
particles budding through the plasma membrane. (C) Infected Vero cells
were permeabilized with streptolysin O at 24 hpi and labeled with
anti-pE120R antibody and protein A-gold (10 nm) before conventional
Epon embedding. Gold particles (arrowheads) decorated the surface of
ASFV particles within the virus factories. Bars, 200 nm.
|
|
The localization of protein pE120R in the virus particle was also
examined by pre-embedding immunolabeling on permeabilized
ASFV-infected
cells. At 24 hpi, infected cells were permeabilized
with streptolysin O
and, after a brief fixation, were incubated
with anti-pE120R antibodies
followed by protein A-gold. As shown
in Fig.
1C, gold particles
decorated the external layer, i.e.,
the capsid, of the icosahedral
particles present at the assembly
sites. Altogether, immunoelectron
microscopy studies indicate
that protein pE120R is a capsid component
exposed on the surface
of the intracellular
virions.
Protein pE120R interacts with the major capsid protein p72.
Based on in vitro binding assays with purified pE120R protein and on
coimmunoprecipitation experiments with anti-pE120R antibodies, Martínez-Pomares et al. (30) found that protein
pE120R binds to a late virus-induced polypeptide of 72 kDa. To
ascertain whether this polypeptide is the major capsid protein p72,
uninfected and ASFV-infected cells were labeled with
[35S]methionine-[35S]cysteine from 16 to 18 hpi and then immunoprecipitated with anti-pE120R antibody. As
previously described (30) and as shown in Fig.
2A (upper panel), the anti-pE120R
antibodies immunoprecipitated several low-molecular-mass proteins
ranging from 14.5 to 22 kDa, which correspond to the different pE120R
forms, as well as an additional 72-kDa polypeptide that was not
detected in uninfected cells. The identity of this protein was
ascertained by Western immunoblotting with MAb 17L.D3 against p72
(27, 41) of the material previously immunoprecipitated
with anti-pE120R antibody. As shown in Fig. 2A (lower panel), a 72-kDa
protein band comigrating with the major capsid protein from highly
purified virus was detected.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 2.
Protein pE120R interacts with the major capsid protein
p72. (A) Uninfected (U) Vero cells or cells infected with BA71V virus
(I) were pulse-labeled with
[35S]methionine-[35S]cysteine from 16 to 18 hpi. The cell extracts were immunoprecipitated with anti-pE120R serum
and analyzed by SDS-polyacrylamide gel electrophoresis and
autoradiography (upper panel). The immunoprecipitated material from
infected cell extracts was further analyzed, together with highly
purified extracellular ASFV (V), by Western immunoblotting with
anti-p72 MAb 17L.D3 (lower panel). (B) Western immunoblotting with MAb
anti-p72 (upper panel) and anti-pE120R (lower panel) antibodies of
cytosolic (C) and membrane-particulate (M) fractions from uninfected
cells (U) or cells infected with parental BA71V (I). Analysis of highly
purified extracellular virions (V) is also shown. The asterisk
indicates the position of the major structural pE120R form of 12 kDa.
(C) Infected Vero cells were pulse-labeled with
[35S]methionine-[35S]cysteine from 11 to 12 hpi (P1), chased for 3 h (C3) and 24 h (C24), and then
fractionated into soluble cytosolic (C), membrane-particulate (M), and
extracellular virus (V) fractions. Equivalent amounts of the fractions
were immunoprecipitated with anti-pE120R antibodies and analyzed by
SDS-polyacrylamide gel electrophoresis. The asterisk indicates the
position of the major structural pE120R form of 12 kDa. (D)
Immunoblotting with anti-p72 (upper panel) and anti-pE120R (lower
panel) antibodies of cytosolic (C) and membrane-particulate (M)
fractions from extracts of vA72-infected cells grown in the presence
(vA72+) or in the absence (vA72 ) of IPTG. The migration position of
molecular mass markers is indicated on the left. The bands
corresponding to protein p72 and the different forms of protein pE120R
are indicated on the right.
|
|
Incorporation of protein pE120R into the virus particle depends on
expression of the major capsid protein p72.
To further explore the
relationship between the capsid proteins pE120R and p72, we analyzed
their intracellular distribution. Mock- and BA71V-infected cells were
fractionated at 24 hpi into a soluble and a membrane-particulate
cytoplasmic fraction as described in Materials and Methods. A Western
blot analysis showed that protein p72, a peripheral membrane protein
(17), was essentially present in the membrane-particulate
fraction (Fig. 2B, upper panel). In contrast, protein pE120R was
predominantly cytosolic, although a significant proportion was also
detected in the membrane-particulate cytoplasm (Fig. 2B, lower panel).
Interestingly, some pE120R forms, ranging from 14.5 to 22 kDa, were
mainly found in the cytosol, while others, ranging from 12 to 25 kDa,
were present almost exclusively in the cytoplasmic sediment. Moreover,
the analysis of protein pE120R in highly purified extracellular ASFV
revealed a multiple band profile resembling that observed in the
membrane-particulate cell fraction, although with some
significant differences. As shown in Fig. 2B (lower panel), the main
difference was the detection of a prominent 12-kDa structural form
which was almost undetectable in the cytoplasmic sediment. This
striking mass heterogeneity of protein pE120R suggests that the protein
undergoes posttranslational modifications before and during its
incorporation to the intracellular virus particle, as well as during or
after virus release. To evaluate whether the species found in the
membrane-particulate and extracellular virus fractions are derived from
the cytosolic pE120R forms, we analyzed the subcellular distribution of
pE120R in a pulse-chase experiment. ASFV-infected cells were labeled
with [35S]methionine-[35S]cysteine from 11 to 12 hpi and then chased in the presence of cold methionine-cysteine
for different periods. After the pulse and chase periods, the infected
cells were fractionated into a soluble and a membrane-particulate
fraction and the extracellular medium was centrifuged to collect
extracellular released virions. Equivalent amounts of the fractions
were then analyzed by immunoprecipitation with anti-pE120R antibodies.
As shown in Fig. 2C, protein pE120R (as 14.5- to 22-kDa isoforms) and
coprecipitated protein p72 were essentially detected in the soluble
cytoplasmic fraction after the 1-h pulse-labeling. Following a 3-h
chase, pE120R and p72 levels slightly decreased in the cytosol and,
concomitantly, slightly increased in the cytoplasmic sediment. Finally,
after a 24-h chase, proteins pE120R (as 12- to 25-kDa isoforms) and p72
were mostly detected in the membrane-particulate and extracellular
virus fractions. These results indicate that protein pE120R is
initially expressed in the cytosol and subsequently, a fraction of it
is slowly incorporated into the assembling virus particles, with the
appearance of some new species. On the other hand, since anti-pE120R
antibodies coimmunoprecipitated both proteins pE120R and p72 from the
pulse-labeled cytosolic extract, it seems that pE120R associates with
cytosolic p72 before its incorporation into the assembling virions.
We next investigated if the intracellular distribution of protein
pE120R is dependent on p72 expression using an ASFV recombinant
(vA72)
which inducibly expresses the major capsid protein (
27).
Vero cells were infected for 24 h with recombinant vA72 in the
presence or absence of IPTG and subsequently fractionated as described
above. As shown in Fig.
2D, under permissive conditions both protein
p72 and pE120R fractionated as in control BA71V infections. In
contrast, when p72 expression was abrogated, protein pE120R was
detected almost exclusively in the soluble cytoplasmic fraction.
The
virtual absence of protein pE120R in the membrane-particulate
sediment
indicates that p72 expression influences the intracellular
distribution
of
pE120R.
To further investigate this effect, immunoelectron microscopy with the
anti-pE120R and anti-p72 antibodies was performed on
sections of
vA72-infected cells maintained for 16 h in the absence
of IPTG (Fig.
3A
and C) or treated with the inducer at 16 hpi
during an additional 8-h period (Fig.
3B and D). As previously
reported, the effect of p72 repression was the accumulation of
aberrant
virus forms, called zipper-like structures, at the virus
factories
(
5,
27). These structures consist of an extended
central
domain, which is reminiscent of the core shell, flanked
by inner viral
envelopes. As shown in Fig.
3A, these zipper-like
structures were
poorly labeled with the anti-pE120R, which is
consistent with the
cytosolic distribution of protein pE120R observed
under these
conditions (Fig.
2C). As a negative control, the anti-p72
labeling was
practically absent (Fig.
3C). After addition of the
inducer, p72
expression led to the capsid assembly on the previously
accumulated
zipper-like structures, as well as to the de novo
formation of normal
virions (
27). In these conditions, both
anti-pE120R (Fig.
3B) and anti-p72 (Fig.
3D) antibodies strongly
labeled the nascent
icosahedral particles, as well as the zipper-like
structures,
especially in the areas where assembling capsids were
evident.

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoelectron microscopy of protein pE120R on
vA72-infected cells. Lowicryl sections of vA72-infected cells
maintained 16 h in the absence of IPTG (A and C) or treated with
the inducer at 16 hpi during an 8-h period (B and D) were incubated
with anti-pE120R antibody (A and B) or anti-p72 antibody (C and D),
followed by protein A-gold (10 nm). In the absence of IPTG the aberrant
zipper-like structures were poorly labeled by both sera while, in the
presence of the inducer, anti-pE120R and anti-p72 antibodies strongly
labeled (arrowheads) icosahedral particles as well as polyhedral forms
derived from previously assembled zipper-like structures. The arrows
indicate icosahedral forms emerging from zipper-like structures. Bars,
200 nm.
|
|
In summary, these results indicate that the incorporation of protein
pE120R to the virus particle is dependent on expression
of the major
capsid protein p72 and probably concomitant to capsid
assembly.
Inducible expression of protein pE120R by recombinant virus
vE120Ri.
To further analyze the role of protein pE120R in
virus replication, we constructed an ASFV recombinant (vE120Ri),
derived from the parental BA71V strain, enabling the inducible
expression of gene E120R (Fig. 4A). In
this recombinant virus, the endogenous gene E120R was replaced by a
copy under the transcriptional control of the inducible late promoter
p72.1 consisting of the strong late promoter
p72.4 (27) and the operator sequence
O1 from the E. coli lac operon (Fig. 4A).
Expression of gene E120R is regulated by the E. coli lac
repressor encoded by gene lacI, which was inserted within
the nonessential tk locus under the control of the early promoter pU104 (2).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Genomic structure of the recombinant ASFV virus
vE120Ri. Recombinant virus vE120Ri was obtained from recombinant
vGUSREP, which contains the lacI gene encoding the
lac repressor inserted into the nonessential tk
locus. In vE120Ri virus, the gene E120R is under the transcriptional
control of an inducible promoter p72.1, which is composed by
the strong late promoter p72.4 and the lac
operator sequence ( ). The reporter genes lacZ and
gusA, used for selection and purification of the
recombinants, are also represented. (B) Plaque phenotype of vE120Ri.
Monolayers of Vero cells were infected in the absence or presence of 1 mM IPTG with parental BA71V or recombinant vE120Ri virus. Plaques were
visualized with 1% crystal violet 5 days after infection. (C)
Inducible expression of protein pE120R. Vero cells were infected with
BA71V or recombinant vE120Ri in the presence (+) or absence ( ) of 1 mM IPTG. At 24 hpi, samples were electrophoresed and analyzed by
Western immunoblotting with a serum anti-pE120R. The electrophoretic
mobility of molecular weight markers is indicated on the left.
|
|
To test the inducer dependence of recombinant vE120Ri, a plaque assay
was performed at different concentrations of IPTG ranging
from 0 to 2 mM (not shown). The plaque number was maximal at 1
mM IPTG. Figure
4B
shows the plaque phenotype of parental BA71V
and recombinant vE120Ri
viruses in the presence or in the absence
of 1 mM IPTG. In the presence
of the inducer, both the number
and the size of the plaques of
recombinant vE120Ri were similar
to those observed for the control
virus. In contrast, in the absence
of IPTG the plaque number of
recombinant vE120Ri was reduced by
about 2.5 orders of
magnitude.
To verify that the plaque phenotype of vE120Ri virus
correlates with the IPTG-dependent expression of protein
pE120R, a Western
blot analysis was performed with extracts of BA71V-
and vE120Ri-infected
cells maintained in the presence or in the absence
of 1 mM IPTG
for 24 hpi. As shown in Fig.
4C, under restrictive
conditions
the expression levels of protein pE120R were dramatically
reduced
with regard to those observed under permissive conditions or in
BA71V infections. A densitometric quantitation showed that, in
the
absence of IPTG, expression of pE120R was 1 and 0.5% of that
observed
under permissive conditions and in control BA71V infections,
respectively. These results indicate that plaque formation by
recombinant vE120Ri is related to pE120R
expression.
Protein pE120R is required for virus dissemination but not for
infectivity.
To study the effect of pE120R shutoff on viral
replication, one-step growth curves were performed. Cells infected with
recombinant vE120Ri in the presence or in the absence of inducer were
harvested in their culture medium at different times postinfection and
titrated by plaque assay under permissive conditions. Surprisingly, no significant difference was observed in the virus yield of recombinant vE120Ri grown under restrictive or permissive conditions, a yield which
was, on the other hand, similar to that obtained for the control BA71V
virus (not shown). To clarify the apparent contradiction between the
plaque assays and the one-step growth curves, infected cells and
culture supernatants were titrated separately after sonication. Figure
5 shows the titration curves of the
extracellular (panel A) and intracellular (panel B) viruses, as well as
the total virus yield (panel C) deduced from those curves. Under
restrictive conditions, the titer of extracellular vE120Ri was, from 24 to 48 hpi, ca 2 log units lower than that obtained under permissive conditions or with the parental virus (Fig. 5A). In contrast, the yield
of cell-associated recombinant virus grown under restrictive conditions
(Fig. 5B) was similar to the total yield of the recombinant grown under
permissive conditions or the parental virus (Fig. 5C). These results
show, on the one hand, that mutant vE120Ri particles are infectious
and, on the other, that protein pE120R is required for virus
dissemination.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
One-step growth curves of vE120Ri. Vero cells were
infected with 10 PFU of BA71V or vE120Ri virus per cell in the presence
or absence of 1 mM IPTG. Virus from the culture supernatants (A) and
the infected cells (B) were collected at the indicated times of
infection and titrated separately by plaque assay on fresh Vero cells
in the presence of the inducer. (C) Curves of total virus yield were
deduced from the intracellular and extracellular virus yields shown in
panels A and B. (D) In the same experiment, recombinant virus vE120Ri
was grown under nonpermissive conditions for the indicated times and
then induced with IPTG. At different times postinfection, extracellular
virus from the culture supernatant was titrated as described above in
the presence of inducer. As a control, the extracellular virus yields
of recombinant vE120Ri grown in the absence or presence of IPTG
throughout the infection are shown.
|
|
In the same experiment, it was also tested the ability of
vE120R-infected cells maintained for different times under
nonpermissive
conditions to produce extracellular infectious virus upon
IPTG
addition. As shown in Fig.
5D, the extracellular virus yield
increased
significantly when IPTG was added at 12 hpi, an early time
for
the virus assembly in normal infections (
4,
10,
31).
However,
when pE120R expression was induced from 16 or 20 hpi onward,
the
extracellular virus titers did not increase significantly compared
to a vE120Ri infection in the absence of IPTG. Since the intracellular
virus yield is considerable at these late times of infection (see
Fig.
5B), these results strongly suggest that the inhibitory effect
of
pE120R repression on virus egress is not reversible (see
below).
Protein pE120R is required for the transport of virions from
the assembly sites to the plasma membrane.
To characterize in more
detail the effect of repression of pE120R on virus egress,
immunofluorescence experiments were performed on vE120Ri-infected cells
maintained for 18 h with or without 1 mM IPTG. Figure
6 shows a double labeling with the rabbit
polyclonal serum against protein pE120R (panels A and C) and the mouse
MAb against protein p72 (panels B and D). In the presence of the
inducer (Fig. 6A and B), both anti-pE120R and anti-p72 antibodies
strongly labeled the virus factories, as well as virus particles
scattered throughout the cytoplasm (see also the inserts in these
panels). In the absence of the inducer, labeling of protein pE120R
(Fig. 6C) was drastically diminished, while an intense signal of p72 (Fig. 6D) was observed only in the assembly sites. These observations strongly suggest that, when expression of protein pE120R is inhibited, intracellular virus particles are retained in the virus factories and
no transport to the cell periphery occurs.

View larger version (124K):
[in this window]
[in a new window]
|
FIG. 6.
Immunofluorescence microscopy of vE120Ri-infected cells.
Vero cells infected with recombinant vE120Ri virus in the presence (A
and B) or absence (C and D) of IPTG were fixed at 18 hpi and
double-labeled with rabbit serum anti-pE120R (A and C) and mouse MAb
17L.D3 anti-p72 (B and D). Labeling was revealed with Alexa 488 goat
anti-rabbit rabbit IgG and with Alexa 594 goat anti-mouse IgG. Insets
in panels A and B show enlarged images of the delimited cytoplasmic
areas. Viral factories and virions spread throughout the cytoplasm are
indicated by arrows and arrowheads, respectively.
|
|
In another approach, electron microscopy (EM) studies were carried out
on sections of vE120Ri-infected cells maintained for
18 h in the
presence (Fig.
7A) or in the absence of 1 mM IPTG
(Fig.
7B to D). When we compared both situations, it was
evident
that under restrictive conditions no budding occurred at the
plasma
membrane and essentially no virus particles were detected
outside
the virus factories (compare Fig.
7A and B). Within the
assembly
areas, all stages of virus morphogenesis, including large
amounts
of apparently mature virions, were observed (Fig.
7C). Close
inspection
of these mutant vE120Ri full particles (Fig.
7D) did not
reveal
any significant ultrastructural difference with normal mature
virions. Interestingly, aberrant structures (Fig.
7D) reminiscent
but
more complex than the zipper-like structures found when p72
expression
is abrogated (
5,
27; see also Fig.
3), were observed
at
the assembly sites. As deduced from the one-step growth curves,
the
existence of such structures did not interfere significantly
with the
production of infectious virus particles. Finally, we
also analyzed
vE120Ri-infected cells maintained under restrictive
conditions for
16 h and then induced with IPTG for 8 h. In agreement
with
the titration experiment shown in Fig.
5D, no significant
transport or
release of previously assembled mature particles
could be detected (not
shown).

View larger version (182K):
[in this window]
[in a new window]
|
FIG. 7.
Electron microscopy of vE120Ri-infected cells. Ultrathin
Epon sections of vE120Ri-infected Vero cells incubated for 18 h in
the presence (A) or in the absence (B, C, and D) of IPTG. While in the
presence of inducer (A) ASFV particles move from the virus factories
(VF) to the plasma membrane to be released by budding, in the absence
of IPTG (B) virus particles are assembled within the virus factories
but neither transport nor budding occur. Note also that, under
restrictive conditions, the factories (panel C) contain all normal
virus assembly stages, including large amounts of intracellular mature
particles. Additionally, some aberrant virus structures can be
detected. Panel D shows a higher magnification of the region delimited
by the dashed line in panel C, which contains an aberrant structure and
two apparently normal intracellular mature particles. Bars: A and B, 1 µm; C and D, 200 nm.
|
|
In conclusion, EM studies indicate that protein pE120R is essential for
the transport of virus particles from the assembly
sites to the plasma
membrane but is not required for the assembly
of morphologically mature
intracellular
particles.
 |
DISCUSSION |
Most of our knowledge on ASFV morphogenesis derives from the
analysis at the electron microscope of the morphological stages of
virus assembly (4, 5, 9, 10, 27, 31) and the immunolocalization of virus proteins on the virus precursors and mature
virions (4, 6, 8, 15, 27). To facilitate the study of
particular ASFV proteins on virus replication, our laboratory recently
adapted to ASFV an inducible expression system based on the E. coli lac operon (27). In this report, we have used this strategy to investigate the role of ASFV protein pE120R.
Protein pE120R was described by Martínez-Pomares et al.
(30) as a structural polypeptide expressed late after
infection as different low-molecular -mass forms that, in our
experiments, range from 12 to 25 kDa. Protein pE120R is 90.8%
identical to its counterpart K3R in the pathogenic Malawi strain
(22) and is expressed in cells infected by a variety of
pathogenic and nonpathogenic virus strains (unpublished results). The
protein lacks significant similarity with other viral and nonviral
protein sequences available in the databases. Interestingly,
Martínez-Pomares et al. (30) found that protein
pE120R binds to a late-virus-induced protein of 72 kDa. By using
coimmunoprecipitation assays, we show here that this polypeptide is the
major capsid protein p72. This interaction is consistent with the
external localization of protein pE120R in the virus particles.
Immunoelectron microscopy showed that protein pE120R is mainly present
in polyhedral virus particles, being exposed on the capsid of the
intracellular mature virion. Using a recombinant virus that inducibly
expresses protein p72 (27), we also found that expression
of the major capsid protein is required for the association of protein
pE120R with the virus. Taking into account that capsid protein p72 is a
peripheral membrane protein initially expressed in the cytosol
(17; this report) and that anti-pE120R antibodies
coprecipitate p72 from cytosolic extracts (this report), it is likely
that pE120R associates with assembling virions after being bound to
cytosolic p72. The results also suggest that the incorporation of
protein pE120R into nascent virus particles is concomitant with capsid formation.
Analysis of recombinant vE120Ri led to two important conclusions: (i)
the protein pE120R is required for virus egress, and (ii) it is not
essential for virus infectivity. Repression of pE120R synthesis
drastically inhibited virus release from the host cell, as deduced from
plaque assays and one-step virus growth curves. Immunofluorescence and
immunoelectron microscopy revealed that this effect was a consequence
of the retention of the intracellular mature particles within the viral
factories. Collectively, these data indicate that pE120R expression is
required for the transport of intracellular particles from the assembly
sites to the plasma membrane. Interestingly, the induction of pE120R
expression in vE120Ri-infected cells previously maintained for long
periods under restrictive conditions did not significantly increase
virus egress. The apparent irreversibility of the mutant phenotype
suggests that newly synthesized protein pE120R is not able to associate with previously assembled mutant particles. This result supports the
view that protein pE120R is recruited during capsid formation in normal
infections, although it is not strictly essential for the assembly of
the capsid layer nor for the production of intracellular infectious particles.
In general, virus movement during entry and exit from the host cell is
dependent on the cytoskeleton (20, 40, 46, 48), which is
commonly reorganized throughout the infection. With regard to the
association of ASFV with the cytoskeleton, previous work showed a
function of microtubules in the organization of the assembly sites
(3, 16), the redistribution of mitochondria around the
viral factories (37), and virus release (3,
16). Alves de Matos and Carvalho (3) found that
incubation of ASFV-infected cells with drugs that depolymerize
microtubules avoided the fusion of assembly sites into a unique viral
factory that ocurrs in normal infections. Importantly, this treatment
also inhibited strongly the migration of nascent virus particles to the
cell surface, an effect that was reverted after drug removal. On the
other hand, in vitro binding assays and EM studies with taxol-treated
cells indicated that virions bind to microtubules (3). In
this aspect, the involvement of microtubules in the transport of ASFV
particles is analogous to that described for the intracellular movement of vaccinia virus. According to Sanderson et al. (40), the
intracellular mature virus employs microtubules for efficient
dispersion from the viral factories.
Since both protein pE120R and microtubules are required for the
transport of virions to the cell periphery, it is tempting to speculate
that protein pE120R could be involved in the virus-microtubule interaction. The external location of protein pE120R in the
intracellular virion is compatible with such a role. On the other hand,
the striking observation that protein pE120R exhibits different and complex band profiles in the cytosol, the membrane-particulate cytoplasm, and the extracellular virions might reflect a complex maturational process related to the regulation of the interaction with
the microtubules and the subsequent transport of ASFV particles. The
posttranslational modifications involved in the high mass heterogeneity
of protein pE120R have not been elucidated at present, although
glycosylation and disulfide-linked dimerization can be excluded from
the sequence data (30). A more detailed study of protein
pE120R will be necessary to determine the exact function of this
protein in virus dissemination and to identify the basis of its size heterogeneity.
With regard to the infectivity of mutant vE120Ri, the results of this
work support the idea that the intracellular mature form of ASFV is
infectious. Under conditions that abrogate pE120R expression and virus
egress, the intracellular virus yield was similar to the total yield
obtained under permissive conditions or with parental BA71V virus.
Consistent with this, EM studies showed that under restrictive
conditions large amounts of intracellular mature particles,
structurally indistinguishable from normal BA71V virions, are assembled
at the virus factories. Previous work showed that protein pE120R has
DNA-binding properties in vitro (30), which could suggest
a potential role in DNA replication, DNA encapsidation, or proper
assembly of the nucleoprotein core. Nevertheless, the localization
of pE120R in the virus particle and the phenotype of recombinant
vE120Ri do not support any essential function for pE120R related to its
DNA-binding properties. Since protein pE120R binds to DNA with a low
affinity constant (30), it cannot be excluded that this
interaction merely reflects its ability to bind to negatively charged macromolecules.
The infectivity of intracellular vE120Ri particles is consistent with
early work showing that preparations of partially purified cell-associated ASFV particles are infectious (42), that
the outer viral envelope is not necessary for infectivity
(42), and that antibodies against the capsid protein p72
can neutralize ASFV infection (7, 28). Unlike
extracellular virions (12), intracellular mature particles
have not been efficiently purified so far mainly due to their high
contamination with cellular membranes as well as extracellular
particles, which often lose the outer envelope (42). In
relation to this, the recombinant vE120Ri can be a useful tool to
purify intracellular ASFV mature particles and to establish the
differences in composition and infectivity with the extracellular
enveloped particles. Regarding this point, the existence of
intracellular and extracellular infectious particles, which are
structurally and antigenically distinct, is well established for other
complex DNA viruses such as poxviruses (21, 33). Finally,
it will be important to know if the infectious intracellular form of
ASFV plays a direct role in virus dissemination in vivo. Since ASFV
infection evolves finally toward cytolysis (9), the
release of intracellular virions from lysed cells could constitute an
alternative pathway to the budding at the plasma membrane. In such a
case, the existence of two structurally and antigenically different
infectious ASFV particles may have important implications in the host
immune response against ASFV.
 |
ACKNOWLEDGMENTS |
We thank J. Salas and A. Alejo for critical reading of the
manuscript. We also thank M. Guerra, M. Rejas, and M. J. Bustos for technical assistance.
This study was supported by grants from the Dirección General de
Investigación Científica y Técnica (PB96-0902-C02
-01), the European Community (FAIR-CT97-3441), and the Ministerio de Educación y Cultura (AGF98-1352-CE) and by an institutional grant from Fundación Ramón Areces. G. Andrés was supported
by a fellowship from Comunidad Autónoma de Madrid.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Centro de
Biología Molecular "Severo Ochoa" (CSIC-UAM), Facultad de
Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain. Phone: 34-91-397-84-38. Fax: 34-91-397-47-99. E-mail:
gandres{at}cbm.uam.es.
Deceased. This work is dedicated to his memory.
 |
REFERENCES |
| 1.
|
Alcamí, A.,
A. Angulo,
C. López-Otín,
M. Muñoz,
J. M. P. Freije,
A. L. Carrascosa, and E. Viñuela.
1992.
Amino acid sequence and structural properties of protein p12, an African swine fever virus attachment protein.
J. Virol.
66:3860-3868[Abstract/Free Full Text].
|
| 2.
|
Almazán, F.,
J. M. Rodríguez,
G. Andrés,
R. Pérez,
E. Viñuela, and J. F. Rodríguez.
1992.
Transcriptional analysis of multigene family 110 of African swine fever virus.
J. Virol.
66:6649-6654[Abstract/Free Full Text].
|
| 3.
|
Alves de Matos, A. P., and Z. G. Carvalho.
1993.
African swine fever virus interaction with microtubules.
Biol. Cell
78:229-234[CrossRef][Medline].
|
| 4.
|
Andrés, G.,
C. Simón-Mateo, and E. Viñuela.
1997.
Assembly of African swine fever virus: role of polyprotein pp220.
J. Virol.
71:2331-2341[Abstract].
|
| 5.
|
Andrés, G.,
R. García-Escudero,
C. Simón-Mateo, and E. Viñuela.
1998.
African swine fever virus is enveloped by a two-membraned collapsed cisterna derived from the endoplasmic reticulum.
J. Virol.
72:8988-9001[Abstract/Free Full Text].
|
| 6.
|
Andrés, G.,
A. Alejo,
C. Simón-Mateo, and M. L. Salas.
2001.
African swine fever virus protease: a new viral member of the SUMO-1-specific protease family.
J. Biol. Chem.
276:780-787[Abstract/Free Full Text].
|
| 7.
|
Borca, M. V.,
P. M. Irusta,
C. Carrillo,
C. L. Afonso,
T. Burrage, and D. L. Rock.
1994.
African swine fever virus structural protein p72 contains a conformational neutralizing epitope.
Virology
201:413-418[CrossRef][Medline].
|
| 8.
|
Borca, M. V.,
P. M. Irusta,
G. F. Kutish,
C. Carrillo,
C. L. Afonso,
T. Burrage, and D. L. Rock.
1996.
A structural DNA-binding protein of African swine fever virus with similarity to bacterial histone-like proteins.
Arch. Virol.
141:301-313[CrossRef][Medline].
|
| 9.
|
Breese, S. S., Jr., and C. J. DeBoer.
1966.
Electron microscope observation of African swine fever virus in tissue culture cells.
Virology
28:420-428[CrossRef][Medline].
|
| 10.
|
Brookes, S. M.,
L. K. Dixon, and R. M. E. Parkhouse.
1996.
Assembly of African swine fever virus: quantitative ultrastructural analysis in vitro and in vivo.
Virology
224:84-92[CrossRef][Medline].
|
| 11.
|
Brookes, S. M.,
A. D. Hyatt,
T. Wise, and R. M. E. Parkhouse.
1998.
Intracellular virus DNA distribution and the acquisition of the nucleoprotein core during African swine fever virus particle assembly: ultrastructural in situ hybridisation and DNase-gold labelling.
Virology
249:175-188[CrossRef][Medline].
|
| 12.
|
Carrascosa, A. L.,
M. del Val,
J. F. Santarén, and E. Viñuela.
1985.
Purification and properties of African swine fever virus.
J. Virol.
54:337-344[Abstract/Free Full Text].
|
| 13.
|
Carrascosa, A. L.,
I. Sastre, and E. Viñuela.
1991.
African swine fever virus attachment protein.
J. Virol.
65:2283-2289[Abstract/Free Full Text].
|
| 14.
|
Carrascosa, J. L.,
J. M. Carazo,
A. L. Carrascosa,
N. García,
A. Santisteban, and E. Viñuela.
1984.
General morphology and capsid fine structure of African swine fever virus particles.
Virology
132:160-172[CrossRef][Medline].
|
| 15.
|
Carrascosa, J. L.,
P. González,
A. L. Carrascosa,
B. García-Barreno,
L. Enjuanes, and E. Viñuela.
1986.
Localization of structural proteins in African swine fever virus particles by immunoelectron microscopy.
J. Virol.
58:377-384[Abstract/Free Full Text].
|
| 16.
|
Carvalho, Z. G.,
A. P. Alves de Matos, and C. Rodrigues-Pousada.
1988.
Association of African swine fever virus with the cytoskeleton.
Virus Res.
11:175-192[CrossRef][Medline].
|
| 17.
|
Cobbold, C.,
J. T. Whittle, and T. Wileman.
1996.
Involvement of the endoplasmic reticulum in the assembly and envelopment of African swine fever virus.
J. Virol.
70:8382-8390[Abstract].
|
| 18.
|
Cobbold, C.,
S. M. Brookes, and T. Wileman.
2000.
Biochemical requirements of virus wrapping by the endoplasmic reticulum: involvement of ATP and endoplasmic reticulum calcium store during envelopment of African swine fever virus.
J. Virol.
74:2151-2160[Abstract/Free Full Text].
|
| 19.
|
Costa, J. V.
1990.
African swine fever virus, p. 247-270.
In
G. Darai (ed.), Molecular biology of iridoviruses. Kluwer Academic Publishers, Boston, Mass.
|
| 20.
|
Cudmore, S.,
P. Cossart,
G. Griffiths, and M. Way.
1995.
Actin-based motility of vaccinia virus.
Nature
378:636-638[CrossRef][Medline].
|
| 21.
|
Dales, S., and B. G. T. Pogo.
1981.
Biology of poxviruses.
Virol. Monogr.
18:54-64.
|
| 22.
|
Dixon, L. K.,
S. R. F. Twigg,
S. A. Baylis,
S. Vydelingum,
C. Bristow,
J. M. Hammond, and G. L. Smith.
1994.
Nucleotide sequence and variability of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1).
J. Gen. Virol.
75:1655-1684[Abstract/Free Full Text].
|
| 23.
|
Dixon, L. K.,
J. V. Costa,
J. M. Escribano,
D. L. Rock,
E. Viñuela, and P. J. Wilkinson.
2000.
The Asfarviridae, p. 159-165.
In
M. H. V. Van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carsten, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle, and R. B. Wickner (ed.), Virus taxonomy. Seventh Report of the International Committee for the Taxonomy of Viruses. Academic Press, New York, N.Y.
|
| 24.
|
Enjuanes, L.,
A. L. Carrascosa,
M. A. Moreno, and E. Viñuela.
1976.
Titration of African swine fever virus.
J. Gen. Virol.
32:471-477[Abstract/Free Full Text].
|
| 25.
|
Esteves, A.,
M. I. Marques, and J. V. Costa.
1986.
Two-dimensional analysis of African swine fever virus proteins and proteins induced in infected cells.
Virology
152:192-206[CrossRef][Medline].
|
| 26.
|
García, R.,
F. Almazán,
J. M. Rodríguez,
M. Alonso,
E. Viñuela, and J. F. Rodríguez.
1993.
Vectors for the genetic manipulation of African swine fever virus.
J. Biotechnol.
40:121-131.
|
| 27.
|
García-Escudero, R.,
G. Andrés,
F. Almazán, and E. Viñuela.
1998.
Inducible gene expression from African swine fever virus recombinants: analysis of the major capsid protein p72.
J. Virol.
72:3185-3195[Abstract/Free Full Text].
|
| 28.
|
Gomez-Puertas, P.,
F. Rodríguez,
J. M. Oviedo,
F. Ramiro-Ibañez,
F. Ruiz-Gonzalvo,
C. Alonso, and J. M. Escribano.
1996.
Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization.
J. Virol.
70:5689-5694[Abstract/Free Full Text].
|
| 29.
|
González, A.,
A. Talavera,
J. M. Almendral, and E. Viñuela.
1986.
Hairpin loop structure of African swine fever virus DNA.
Nucleic Acids Res.
14:6835-6844[Abstract/Free Full Text].
|
| 30.
|
Martínez-Pomares, L.,
C. Simón-Mateo,
C. López-Otín, and E. Viñuela.
1997.
Characterization of the African swine fever virus structural protein p14.5: a DNA binding protein.
Virology
229:201-211[CrossRef][Medline].
|
| 31.
|
Moura Nunes, J. F.,
J. D. Vigario, and A. M. Terrinha.
1975.
Ultrastructural study of African swine fever virus replication in cultures of swine bone marrow cells.
Arch. Virol.
49:59-66[CrossRef][Medline].
|
| 32.
|
Muñoz, M,
J. M. P. Freije,
M. L. Salas,
E. Viñuela, and C. López-Otín.
1993.
Structure and expression in Escherichia coli of the gene coding for protein p10 of African swine fever virus.
Arch. Virol.
130:93-107[CrossRef][Medline].
|
| 33.
|
Payne, L. G.
1980.
Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
J. Gen. Virol.
50:89-100[Abstract/Free Full Text].
|
| 34.
|
Rodríguez, F.,
C. Alcaraz,
A. Eiras,
R. J. Yáñez,
J. M. Rodríguez,
C. Alonso,
J. F. Rodríguez, and J. M. Escribano.
1994.
Characterization and molecular basis of heterogeneity of the African swine fever virus protein p54.
J. Virol.
68:7244-7252[Abstract/Free Full Text].
|
| 35.
|
Rodríguez, J. M.,
F. Almazán,
E. Viñuela, and J. F. Rodríguez.
1992.
Genetic manipulation of African swine fever virus: construction of recombinant viruses expressing the -galactosidase gene.
Virology
188:239-250.
|
| 36.
|
Rodríguez, J. M.,
F. Almazán,
R. J. Yáñez,
R. García,
E. Viñuela, and J. F. Rodríguez.
1995.
African swine fever virus membrane-associated and secreted proteins, p. 187-200.
In
G. McFadden (ed.), Viroceptors, virokines and related immune modulators encoded by DNA viruses. R. G. Landes Company, Austin, Tex.
|
| 37.
|
Rojo, G.,
M. Chamorro,
M. L. Salas,
E. Viñuela,
J. M. Cuezva, and J. Salas.
1998.
Migration of mitochondria to viral assembly sites in African swine fever virus-infected cells.
J. Virol.
72:7583-7588[Abstract/Free Full Text].
|
| 38.
|
Roullier, I.,
S. M. Brookes,
A. D. Hyatt,
M. Windsor, and T. Wileman.
1998.
African swine fever virus is wrapped by the endoplasmic reticulum.
J. Virol.
72:2373-2387[Abstract/Free Full Text].
|
| 39.
|
Salas, J.,
M. L. Salas, and E. Viñuela.
1999.
African swine fever virus: a missing link between poxviruses and iridoviruses?, p. 467-480.
In
E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, London, England.
|
| 40.
|
Sanderson, C. M.,
M. Hollinshead, and G. L. Smith.
2000.
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature particles.
J. Gen. Virol.
81:47-58[Abstract/Free Full Text].
|
| 41.
|
Sanz, A.,
B. García-Barreno,
M. L. Nogal,
E. Viñuela, and L. Enjuanes.
1985.
Monoclonal antibodies specific for African swine fever virus proteins.
J. Virol.
54:199-206[Abstract/Free Full Text].
|
| 42.
|
Schloer, G. M.
1985.
Polypeptides and structure of African swine fever virus.
Virus Res.
3:295-310[CrossRef][Medline].
|
| 43.
|
Simón-Mateo, C.,
G. Andrés, and E. Viñuela.
1993.
Polyprotein processing in African swine fever virus: a novel gene expression strategy for a DNA virus.
EMBO J.
12:2977-2987[Medline].
|
| 44.
|
Simón-Mateo, C.,
G. Andrés,
F. Almazán, and E. Viñuela.
1997.
Proteolytic processing in African swine fever virus: evidence for a new structural polyprotein, pp62.
J. Virol.
71:5799-5804[Abstract].
|
| 45.
|
Sodeik, B.,
R. W. Doms,
M. Ericsson,
G. Hiller,
C. E. Machamer,
W. van't Hof,
G. van Meer,
B. Moss, and G. Griffiths.
1993.
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.
J. Cell Biol.
121:521-541[Abstract/Free Full Text].
|
| 46.
|
Sodeik, B.,
M. W. Ebersold, and A. Helenius.
1997.
Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus.
J. Cell Biol.
136:1007-1021[Abstract/Free Full Text].
|
| 47.
|
Sogo, J. M.,
J. M. Almendral,
A. Talavera, and E. Viñuela.
1984.
Terminal and internal inverted repetitions in African swine fever virus DNA.
Virology
133:271-275[CrossRef][Medline].
|
| 48.
|
Suomalainen, M.,
M. Y. Nakano,
S. Keller,
K. Boucke,
R. P. Stidwill, and U. F. Greber.
1999.
Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus.
J. Cell Biol.
144:657-672[Abstract/Free Full Text].
|
| 49.
|
Viñuela, E.
1987.
Molecular biology of African swine fever virus, p. 31-49.
In
Y. Becker (ed.), African swine fever. Nijhoff, Boston, Mass.
|
| 50.
|
Yáñez, R. J.,
J. M. Rodríguez,
M. L. Nogal,
L. Yuste,
C. Enriquez,
J. F. Rodríguez, and E. Viñuela.
1995.
Analysis of the complete nucleotide sequence of African swine fever virus.
Virology
208:249-278[CrossRef][Medline].
|
Journal of Virology, August 2001, p. 6758-6768, Vol. 75, No. 15
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.6758-6768.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rodriguez, I., Nogal, M. L., Redrejo-Rodriguez, M., Bustos, M. J., Salas, M. L.
(2009). The African Swine Fever Virus Virion Membrane Protein pE248R Is Required for Virus Infectivity and an Early Postentry Event. J. Virol.
83: 12290-12300
[Abstract]
[Full Text]
-
Netherton, C. L., Simpson, J., Haller, O., Wileman, T. E., Takamatsu, H.-H., Monaghan, P., Taylor, G.
(2009). Inhibition of a Large Double-Stranded DNA Virus by MxA Protein. J. Virol.
83: 2310-2320
[Abstract]
[Full Text]
-
Epifano, C., Krijnse-Locker, J., Salas, M. L., Rodriguez, J. M., Salas, J.
(2006). The African Swine Fever Virus Nonstructural Protein pB602L Is Required for Formation of the Icosahedral Capsid of the Virus Particle. J. Virol.
80: 12260-12270
[Abstract]
[Full Text]
-
Epifano, C., Krijnse-Locker, J., Salas, M. L., Salas, J., Rodriguez, J. M.
(2006). Generation of Filamentous Instead of Icosahedral Particles by Repression of African Swine Fever Virus Structural Protein pB438L. J. Virol.
80: 11456-11466
[Abstract]
[Full Text]
-
Wileman, T.
(2006). Aggresomes and autophagy generate sites for virus replication.. Science
312: 875-878
[Abstract]
[Full Text]
-
Jouvenet, N., Wileman, T.
(2005). African swine fever virus infection disrupts centrosome assembly and function. J. Gen. Virol.
86: 589-594
[Abstract]
[Full Text]
-
Jouvenet, N., Monaghan, P., Way, M., Wileman, T.
(2004). Transport of African Swine Fever Virus from Assembly Sites to the Plasma Membrane Is Dependent on Microtubules and Conventional Kinesin. J. Virol.
78: 7990-8001
[Abstract]
[Full Text]
-
Rodriguez, J. M., Garcia-Escudero, R., Salas, M. L., Andres, G.
(2004). African Swine Fever Virus Structural Protein p54 Is Essential for the Recruitment of Envelope Precursors to Assembly Sites. J. Virol.
78: 4299-4313
[Abstract]
[Full Text]
-
Alejo, A., Andres, G., Salas, M. L.
(2003). African Swine Fever Virus Proteinase Is Essential for Core Maturation and Infectivity. J. Virol.
77: 5571-5577
[Abstract]
[Full Text]
-
Andres, G., Alejo, A., Salas, J., Salas, M. L.
(2002). African Swine Fever Virus Polyproteins pp220 and pp62 Assemble into the Core Shell. J. Virol.
76: 12473-12482
[Abstract]
[Full Text]
-
Andres, G., Garcia-Escudero, R., Salas, M. L., Rodriguez, J. M.
(2002). Repression of African Swine Fever Virus Polyprotein pp220-Encoding Gene Leads to the Assembly of Icosahedral Core-Less Particles. J. Virol.
76: 2654-2666
[Abstract]
[Full Text]